ADAM10 and neoplasm: We obtained preliminary evidence that HL tumor cells and MSC Exo can actively process recombinant or endogenous ADAM10 targets, such as TNFα and FasL, in in vitro assays with intact Exo; this indicates that some substrates are accessible to the ADAM10 carried by purified Exo, whatever its orientation inside these vesicles.